Plg Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.93 M
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
- Revenue Growth -12.87%
- Profit Growth -27.24%
- Ebitda -15.48%
- Net Worth 19.90%
- Total Assets -0.72%
About Plg Pharmaceuticals
Plg Pharmaceuticals Private Limited (PPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 April 2005 and has a history of 19 years and nine months. Its registered office is in Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.93 M.
The company currently has active open charges totaling ₹2.50 M.
Sunil Sharma, Shatrughan Shukla, and Vikas Chail serve as directors at the Company.
Company Details
-
Location
Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2005PTC135304
-
Company No.
135304
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Apr 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Plg Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Sharma
|
Additional Director | 23-May-2023 | Current |
|
Shatrughan Shukla
|
Director | 17-Jan-2017 | Current |
|
Vikas Chail
|
Director | 17-Jan-2017 | Current |
Financial Performance of Plg Pharmaceuticals.
Plg Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.87% decrease. The company also saw a substantial fall in profitability, with a 27.24% decrease in profit. The company's net worth Soared by an impressive increase of 19.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plg Pharmaceuticals?
In 2023, Plg Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Elmac Remedies Private Limited.Shatrughan Shukla and Vikas Chail are mutual person
Charges (Loans)
₹2.50 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Dec 2008 | Bank Of Baroda | ₹1.00 M | Open |
| 15 Dec 2008 | Bank Of Baroda | ₹1.50 M | Open |
How Many Employees Work at Plg Pharmaceuticals?
Unlock and access historical data on people associated with Plg Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plg Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plg Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
